Annual D&A
$3.54 M
+$587.00 K+19.85%
December 31, 2024
Summary
- As of March 9, 2025, ARCT annual depreciation & amortization is $3.54 million, with the most recent change of +$587.00 thousand (+19.85%) on December 31, 2024.
- During the last 3 years, ARCT annual D&A has risen by +$2.35 million (+197.07%).
- ARCT annual D&A is now at all-time high.
Performance
ARCT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$819.00 K
-$93.00 K-10.20%
December 31, 2024
Summary
- As of March 9, 2025, ARCT quarterly depreciation & amortization is $819.00 thousand, with the most recent change of -$93.00 thousand (-10.20%) on December 31, 2024.
- Over the past year, ARCT quarterly D&A has dropped by -$90.00 thousand (-9.90%).
- ARCT quarterly D&A is now -10.20% below its all-time high of $912.00 thousand, reached on September 30, 2024.
Performance
ARCT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$3.54 M
+$4000.00+0.11%
December 31, 2024
Summary
- As of March 9, 2025, ARCT TTM depreciation & amortization is $3.54 million, with the most recent change of +$4000.00 (+0.11%) on December 31, 2024.
- Over the past year, ARCT TTM D&A has increased by +$89.00 thousand (+2.58%).
- ARCT TTM D&A is now at all-time high.
Performance
ARCT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ARCT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.9% | -9.9% | +2.6% |
| 3 y3 years | +197.1% | +96.4% | +175.6% |
| 5 y5 years | +418.1% | +96.4% | +175.6% |
ARCT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +197.1% | -10.2% | +265.6% | at high | +219.3% |
| 5 y | 5-year | at high | +418.1% | -10.2% | +435.3% | at high | +418.1% |
| alltime | all time | at high | >+9999.0% | -10.2% | >+9999.0% | at high | >+9999.0% |
Arcturus Therapeutics Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $3.54 M(+19.9%) | $819.00 K(-10.2%) | $3.54 M(+0.1%) |
| Sep 2024 | - | $912.00 K(+0.3%) | $3.54 M(+2.5%) |
| Jun 2024 | - | $909.00 K(+0.6%) | $3.46 M(+5.2%) |
| Mar 2024 | - | $904.00 K(+10.9%) | $3.28 M(+11.0%) |
| Dec 2023 | $2.96 M(+93.6%) | $815.00 K(-1.5%) | $2.96 M(+9.8%) |
| Sep 2023 | - | $827.00 K(+12.2%) | $2.69 M(+18.0%) |
| Jun 2023 | - | $737.00 K(+27.5%) | $2.28 M(+21.4%) |
| Mar 2023 | - | $578.00 K(+4.9%) | $1.88 M(+23.2%) |
| Dec 2022 | $1.53 M(+28.0%) | $551.00 K(+32.1%) | $1.53 M(+18.7%) |
| Sep 2022 | - | $417.00 K(+24.5%) | $1.29 M(+11.1%) |
| Jun 2022 | - | $335.00 K(+49.6%) | $1.16 M(+4.3%) |
| Mar 2022 | - | $224.00 K(-27.7%) | $1.11 M(-7.0%) |
| Dec 2021 | $1.19 M(+35.3%) | $310.00 K(+7.3%) | $1.19 M(+3.6%) |
| Sep 2021 | - | $289.00 K(+0.7%) | $1.15 M(+6.5%) |
| Jun 2021 | - | $287.00 K(-6.5%) | $1.08 M(+7.4%) |
| Mar 2021 | - | $307.00 K(+14.1%) | $1.01 M(+14.2%) |
| Dec 2020 | $882.00 K(+28.9%) | $269.00 K(+22.8%) | $882.00 K(+15.1%) |
| Sep 2020 | - | $219.00 K(+3.3%) | $766.00 K(+5.1%) |
| Jun 2020 | - | $212.00 K(+16.5%) | $729.00 K(+5.0%) |
| Mar 2020 | - | $182.00 K(+19.0%) | $694.00 K(+1.5%) |
| Dec 2019 | $684.00 K(+17.5%) | $153.00 K(-15.9%) | $684.00 K(-2.0%) |
| Sep 2019 | - | $182.00 K(+2.8%) | $698.00 K(+3.4%) |
| Jun 2019 | - | $177.00 K(+2.9%) | $675.00 K(+5.0%) |
| Mar 2019 | - | $172.00 K(+3.0%) | $643.00 K(+10.5%) |
| Dec 2018 | $582.00 K | $167.00 K(+5.0%) | $582.00 K(+11.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $159.00 K(+9.7%) | $524.00 K(+12.2%) |
| Jun 2018 | - | $145.00 K(+30.6%) | $467.00 K(-6.4%) |
| Mar 2018 | - | $111.00 K(+1.8%) | $499.00 K(+21.7%) |
| Dec 2017 | $410.00 K(+39.5%) | $109.00 K(+6.9%) | $410.00 K(-25.2%) |
| Sep 2017 | - | $102.00 K(-42.4%) | $548.00 K(+19.1%) |
| Jun 2017 | - | $177.00 K(+704.5%) | $460.00 K(+52.8%) |
| Mar 2017 | - | $22.00 K(-91.1%) | $301.00 K(+2.4%) |
| Dec 2016 | $294.00 K(+53.1%) | $247.00 K(+1664.3%) | $294.00 K(+45.5%) |
| Sep 2016 | - | $14.00 K(-22.2%) | $202.00 K(-1.0%) |
| Jun 2016 | - | $18.00 K(+20.0%) | $204.00 K(+3.6%) |
| Mar 2016 | - | $15.00 K(-90.3%) | $197.00 K(+2.6%) |
| Dec 2015 | $192.00 K(+519.4%) | $155.00 K(+868.8%) | $192.00 K(+317.4%) |
| Sep 2015 | - | $16.00 K(+45.5%) | $46.00 K(+21.1%) |
| Jun 2015 | - | $11.00 K(+10.0%) | $38.00 K(+8.6%) |
| Mar 2015 | - | $10.00 K(+11.1%) | $35.00 K(+12.9%) |
| Dec 2014 | $31.00 K(+244.4%) | $9000.00(+12.5%) | $31.00 K(+14.8%) |
| Sep 2014 | - | $8000.00(0.0%) | $27.00 K(+35.0%) |
| Jun 2014 | - | $8000.00(+33.3%) | $20.00 K(+42.9%) |
| Mar 2014 | - | $6000.00(+20.0%) | $14.00 K(+55.6%) |
| Dec 2013 | $9000.00(+28.6%) | $5000.00(+400.0%) | $9000.00(+125.0%) |
| Sep 2013 | - | $1000.00(-50.0%) | $4000.00(+33.3%) |
| Jun 2013 | - | $2000.00(+100.0%) | $3000.00(+200.0%) |
| Mar 2013 | - | $1000.00 | $1000.00 |
| Dec 2012 | $7000.00(+16.7%) | - | - |
| Dec 2011 | $6000.00 | - | - |
FAQ
- What is Arcturus Therapeutics Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings annual D&A year-on-year change?
- What is Arcturus Therapeutics Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings quarterly D&A year-on-year change?
- What is Arcturus Therapeutics Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Arcturus Therapeutics Holdings?
- What is Arcturus Therapeutics Holdings TTM D&A year-on-year change?
What is Arcturus Therapeutics Holdings annual depreciation & amortization?
The current annual D&A of ARCT is $3.54 M
What is the all time high annual D&A for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high annual depreciation & amortization is $3.54 M
What is Arcturus Therapeutics Holdings annual D&A year-on-year change?
Over the past year, ARCT annual depreciation & amortization has changed by +$587.00 K (+19.85%)
What is Arcturus Therapeutics Holdings quarterly depreciation & amortization?
The current quarterly D&A of ARCT is $819.00 K
What is the all time high quarterly D&A for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high quarterly depreciation & amortization is $912.00 K
What is Arcturus Therapeutics Holdings quarterly D&A year-on-year change?
Over the past year, ARCT quarterly depreciation & amortization has changed by -$90.00 K (-9.90%)
What is Arcturus Therapeutics Holdings TTM depreciation & amortization?
The current TTM D&A of ARCT is $3.54 M
What is the all time high TTM D&A for Arcturus Therapeutics Holdings?
Arcturus Therapeutics Holdings all-time high TTM depreciation & amortization is $3.54 M
What is Arcturus Therapeutics Holdings TTM D&A year-on-year change?
Over the past year, ARCT TTM depreciation & amortization has changed by +$89.00 K (+2.58%)